| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/KI.2010.265 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ki.2010.265 |
| P953 | full work available at URL | http://www.kidney-international.org/article/S0085253815546619/pdf |
| P698 | PubMed publication ID | 20686447 |
| P50 | author | Toyoshi Inoguchi | Q90437954 |
| P2093 | author name string | Jing Zheng | |
| Ryoichi Takayanagi | |||
| Yasutaka Maeda | |||
| Kunihisa Kobayashi | |||
| Shuji Sasaki | |||
| Masakazu Fujii | |||
| P2860 | cites work | Identification of renox, an NAD(P)H oxidase in kidney | Q22254385 |
| Bilirubin is an antioxidant of possible physiological importance | Q28288206 | ||
| Mechanisms underlying endothelial dysfunction in diabetes mellitus | Q31829307 | ||
| Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice | Q33252362 | ||
| A novel superoxide-producing NAD(P)H oxidase in kidney | Q33921569 | ||
| Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats | Q33989668 | ||
| Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase | Q34216090 | ||
| Vascular NAD(P)H oxidases: specific features, expression, and regulation | Q35175526 | ||
| Heme oxygenase and the cardiovascular-renal system | Q36144605 | ||
| Heme oxygenase and atherosclerosis | Q36195421 | ||
| NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome | Q36198742 | ||
| Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. | Q37001252 | ||
| Protein glycation and oxidative stress in diabetes mellitus and ageing | Q37192112 | ||
| Role of oxidative stress in development of complications in diabetes | Q37681089 | ||
| Induction of haem oxygenase as a defence against oxidative stress | Q37928482 | ||
| Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity | Q38340354 | ||
| Free radicals and diabetes | Q39578509 | ||
| Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems | Q41069909 | ||
| A new method for large scale isolation of kidney glomeruli from mice | Q42047954 | ||
| Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes | Q43867580 | ||
| Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats | Q43972574 | ||
| Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment | Q44589042 | ||
| Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy | Q44599816 | ||
| Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. | Q45918859 | ||
| Statin attenuates high glucose-induced and diabetes-induced oxidative stress in vitro and in vivo evaluated by electron spin resonance measurement | Q46617952 | ||
| Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney | Q46681131 | ||
| Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. | Q51034508 | ||
| Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells | Q63365807 | ||
| Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system | Q67913939 | ||
| Serum bilirubin and risk of ischemic heart disease in middle-aged British men | Q71808154 | ||
| DNA damage in the kidneys of diabetic rats exhibiting microalbuminuria | Q71999728 | ||
| High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells | Q73190327 | ||
| Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice | Q80477528 | ||
| Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes | Q81352389 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 905-919 | |
| P577 | publication date | 2010-08-04 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase | |
| P478 | volume | 78 |
| Q64082950 | Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: A possible role of SGLT2 in mesangial cells |
| Q39022476 | Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds |
| Q58558363 | Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications |
| Q36979415 | Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Diabetic Patients |
| Q33622283 | Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus |
| Q60926275 | Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients |
| Q35813137 | Bile pigments in pulmonary and vascular disease |
| Q34325393 | Bilirubin activates transcription of HIF-1α in human proximal tubular cells cultured in the physiologic oxygen content. |
| Q89524865 | Bilirubin as a signaling molecule |
| Q34727374 | Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis |
| Q35680626 | Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathway |
| Q90437958 | Bilirubin reduces visceral obesity and insulin resistance by suppression of inflammatory cytokines |
| Q64897924 | Bilirubin, a new therapeutic for kidney transplant? |
| Q33959724 | Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy. |
| Q84199219 | Biliverdin protects against the deterioration of glucose tolerance in db/db mice |
| Q49226476 | CAPE-pNO2 ameliorated diabetic nephropathy through regulating the Akt/NF-κB/ iNOS pathway in STZ-induced diabetic mice. |
| Q50975281 | Carbon monoxide exposure improves immune function in lupus-prone mice. |
| Q37831154 | Cardiovascular Complications in CKD Patients: Role of Oxidative Stress. |
| Q38206770 | Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations. |
| Q34496436 | Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus |
| Q34325399 | Effect of bilirubin on triglyceride synthesis in streptozotocin-induced diabetic nephropathy. |
| Q92826618 | FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT |
| Q47888789 | Gilbert syndrome in patients with type 1 diabetes-Prevalence, glycemic control, and microalbuminuria |
| Q27002692 | Haeme oxygenase signalling pathway: implications for cardiovascular disease |
| Q89820050 | Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment? |
| Q37065405 | Heme oxygenase inhibition increases blood pressure in pregnant rats |
| Q37653782 | Heme oxygenase-1: a metabolic nike |
| Q92219736 | Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes |
| Q36185978 | Hyperbilirubinemia exaggerates endotoxin-induced hypothermia. |
| Q37854853 | Impact of dietary soy isoflavones in pregnancy on fetal programming of endothelial function in offspring |
| Q93060657 | In Search of Bioactivity - Phyllobilins, an Unexplored Class of Abundant Heterocyclic Plant Metabolites from Breakdown of Chlorophyll |
| Q38742179 | Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults. |
| Q41607541 | Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus |
| Q36786559 | Mesobiliverdin IXα Enhances Rat Pancreatic Islet Yield and Function. |
| Q36514979 | Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease |
| Q43023265 | NADPH Oxidase 4 at the Nexus of Diabetes, Reactive Oxygen Species, and Renal Metabolism |
| Q37202752 | NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. |
| Q52579097 | Noninvasive Real-Time Characterization of Renal Clearance Kinetics in Diabetic Mice after Receiving Danshensu Treatment. |
| Q38092960 | Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? |
| Q50239710 | Phycocyanin and phycocyanobilin from Spirulina platensis protect against diabetic nephropathy by inhibiting oxidative stress. |
| Q47598149 | Plasma bilirubin and late graft failure in renal transplant recipients |
| Q92431350 | RELATIONSHIP OF OXIDATIVE STRESS TO URINARY ANGIOTENSIN CONVERTING ENZYME 2 IN TYPE 2 DIABETES MELLITUS PATIENTS |
| Q37819453 | Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy |
| Q36825665 | Relationship between Oxidant/Antioxidant Markers and Severity of Microalbuminuria in the Early Stage of Nephropathy in Type 2 Diabetic Patients |
| Q64979019 | Renal impairment markers in type 2 diabetes patients with different types of hyperuricemia. |
| Q36791999 | Renal intramedullary infusion of tempol normalizes the blood pressure response to intrarenal blockade of heme oxygenase-1 in angiotensin II-dependent hypertension |
| Q34486712 | Scalable production of biliverdin IXα by Escherichia coli |
| Q89272258 | Serum bilirubin level and its impact on the progression of chronic kidney disease |
| Q64062894 | Serum bilirubin level is a strong predictor for disability in activities in daily living (ADL) in Japanese elderly patients with diabetes |
| Q87686309 | Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin |
| Q37728038 | Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications |
| Q83493026 | Support for a protective effect of bilirubin on diabetic nephropathy in humans |
| Q92879564 | Targeting Heme Oxygenase-1 in Cardiovascular and Kidney Disease |
| Q90418950 | The Authors Reply |
| Q39048488 | The molecular basis of jaundice: An old symptom revisited. |
| Q35867073 | The role of bilirubin in diabetes, metabolic syndrome, and cardiovascular diseases |
| Q36191720 | The role of oxidative stress in the pathogenesis of diabetic vascular complications |
| Q46861795 | Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosis |
| Q35450699 | Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease |
| Q35112034 | Wld(S) ameliorates renal injury in a type 1 diabetic mouse model |
Search more.